Gilead Sciences (GILD) Earnings Date & Reports

Industry: @Biotechnology

A.I. Advisor

published Earnings

GILD is expected to report earnings to fall 147.60% to $1.59 per share on August 08

Gilead Sciences GILD Stock Earnings Reports

Q2'24

Est.

$1.59

Q1'24

Missed

by $4.90

Q4'23

Missed

by $0.04

Q3'23

Beat

by $0.38

Q2'23

Missed

by $0.31

The last earnings report on April 25 showed earnings per share of -333 cents, missing the estimate of $1.56. With 4.69M shares outstanding, the current market capitalization sits at 90.79B.

View a ticker or compare two or three

Compare

GILD

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For GILD
(Try 14 days for $1 only)

Ad is loading...

A.I.Advisor

published price charts

View to see Real Time Patterns for GILD (Try 14 days for $1 only)

A.I. Advisor

published General Information

General Information

a developer of therapeutic products and treatments for life threatening diseases

Industry PharmaceuticalsMajor

Profile

Fundamentals

Details

Industry

Biotechnology

Address

333 Lakeside Drive

Phone

+1 650 574-3000

Employees

18000

Web

https://www.gilead.com